In Western Africa, Ebola has already killed more than two thousand people, and the Center for Disease Control (CDC) has estimated up to 1.4 million people could contract the deadly virus in the coming months in a worst-case scenario. Despite the growing threat, there is still no therapy that can be distributed at a large-scale. In this time of crisis, CDD wants to make sure that researchers are optimally enabled to discover new drugs to treat and prevent this vicious disease. To this end, CDD is offering the CDD Vault free for a year to any researchers actively engaged in Ebola therapeutic development. CDD Vault’s collaborative tools for organizing and mining structure activity relationships (SAR) will enable drug discovery researchers to work together more easily and efficiently.
CDD strongly believes in the power of collaboration and cheminformatic mining for spurring drug discovery. In fact, a promising antibody therapeutic against Ebola still in development was found via collaboration, and drug repurposing opportunities for Ebola were identified by mining screening data. To learn more about this donation, please contact us at info@collaborativedrug.com.
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!
Tag(s):
CDD Blog
Other posts you might be interested in
View All Posts
CDD Insights
7 min
November 25, 2025
Drug Discovery Industry Roundup with Barry Bunin — November 25 2025
Read More
Webinars
1 min
November 22, 2025
From Hype to Practice: Where AI Actually Helps in Drug Discovery - 2025 Canadian UGM Replay
Read More
CDD Insights
10 min
November 14, 2025
Synthetic Peptides, Nucleotides, Antibodies and Their Drug Conjugates: For Biologists, Chemists and Computers
Read More

